Evidence map›Paper›PMID 40176757›Full record

ArticleHaematologica2025

A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma.

Noa Biran, Eli Zolotov, David Vesole, Harsh Parmar, Pooja Phull, Kimberley Doucette, Patrick Roney, Jaeil Ahn, Rena Feinman, Joshua Zenreich and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Noa BiranJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ, USA; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ. Noa.Biran@hmhn.org.
Eli ZolotovDepartment of Internal Medicine, Hackensack University Medical Center, Hackensack, NJ.
David VesoleJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ, USA; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ.
Harsh ParmarJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ, USA; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ.
Pooja PhullJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ, USA; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ.
Kimberley DoucetteGeorgetown University Medical Center, Washington, DC.
Patrick RoneyDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, DC.
Jaeil AhnJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Rena FeinmanHackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ.
Joshua ZenreichJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Palka AnandJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Monique PaceJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Alexandra Della PiaJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Bianca DeAgrestaJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Lisa BiamonteJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Adolfo AlemanJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Ella RutanenGeorgetown University Medical Center, Washington, DC.
Aimee ChappellJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
Susan KumkaJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
David S SiegelJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA; Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ, USA; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
NCI NIH HHS P30 CA051008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40176757
PMCPMC12485305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.